Home › Funds › Venrock Adviser, LLC › VOR
Venrock Adviser, LLC position in VOR
VOR BIOPHARMA INC · Health Care
Venrock Adviser, LLC reported holding 3,041,719 shares of VOR (VOR BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$58.0M, representing 2.82% of its reported portfolio and ranking #10 among its reported holdings. Venrock Adviser, LLC has disclosed VOR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's VOR position evolved
Venrock Adviser, LLC first disclosed a stake in VOR in Q3 2025 at 499,966 shares (US$24.4M). The position peaked in Q3 2026 at 3,041,719 shares, worth US$58.0M. Across 5 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,041,719 shares valued at US$58.0M. Notable position changes include a 289% increase in Q4 2025 (shares rose 36% over the following quarter), a 56% increase in Q1 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 499.97K | $24.36M | New |
| Q4 2025 | 1.94M | $25.42M | Add |
| Q1 2026 | 3.04M | $54.26M | Add |
| Q2 2026 | 3.04M | $56.00M | Hold |
| Q3 2026 | 3.04M | $58.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VOR and 13F data
VOR (VOR BIOPHARMA INC) is a Health Care company. 70 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$108.2M), RA CAPITAL MANAGEMENT, L.P. (US$85.9M), FCPM III SERVICES B.V. (US$65.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VOR
- TCG Crossover Management, LLC 5.67M sh · $108.24M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.50M sh · $85.93M · Q3 2026
- FCPM III SERVICES B.V. 3.41M sh · $64.97M · Q3 2026
- Frazier Life Sciences Management, L.P. 2.74M sh · $52.35M · Q3 2026
- Caligan Partners LP 1.93M sh · $36.73M · Q3 2026
- GREAT POINT PARTNERS LLC 1.13M sh · $21.50M · Q3 2026
- Nantahala Capital Management, LLC 931.64K sh · $17.78M · Q3 2026
- Paradigm Biocapital Advisors LP 889.58K sh · $16.97M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 721.55K sh · $13.77M · Q3 2026
- NEXTBio Capital Management LP 620.93K sh · $11.85M · Q3 2026
- Rosalind Advisors, Inc. 609.20K sh · $11.62M · Q3 2026
- Vivo Capital, LLC 550.36K sh · $10.50M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held VOR?
Venrock Adviser, LLC has disclosed VOR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Venrock Adviser, LLC's current position in VOR?
As of Q3 2026, Venrock Adviser, LLC holds 3.04M shares of VOR (VOR BIOPHARMA INC), valued at $58.04M, representing 2.82% of its reported portfolio and ranking #10.
Has Venrock Adviser, LLC been buying or selling VOR?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in VOR. The position peaked in Q3 2026 at 3.04M shares.
Which other funds hold VOR?
Other major institutional holders of VOR include TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.